|
CN111773218A
|
|
Application of carboline compound in preparation of drug for resisting human tongue squamous cell carcinoma
|
|
CN111743900A
|
|
Application of carboline derivative in preparation of medicine for treating thyroid cancer
|
|
CN111557935A
|
|
Application of 1-epi-4, 5-dihydroartemisinin C in aspect of treatment of human osteosarcoma
|
|
CN111658637A
|
|
Application of mugwort lactone C in treating human osteosarcoma
|
|
CN109432095A
|
|
A kind of medical usage of thiazoline derivative
|
|
CN109498624A
|
|
A kind of anticancer medical usage of thiazoline derivative
|
|
CN109406685A
|
|
A kind of efficient liquid-phase chromatography method separating Carfilzomib and its isomers
|
|
CN109444294A
|
|
A kind of efficient liquid-phase chromatography method separating Linezolid and its chiral isomer
|
|
CN109432099A
|
|
A kind of application of pyrimidine derivatives in terms for the treatment of thyroid cancer
|
|
CN109453175A
|
|
A kind of application of pyrimidine derivatives in antithyroid cancer
|
|
CN109369581A
|
|
A method of preparing mysorethorn diterpene A
|
|
CN109364081A
|
|
A kind of pyrimidine derivatives are used to treat the purposes of thyroid cancer
|
|
CN109364092A
|
|
A kind of new application of white crane rattan alkali
|
|
CN109432118A
|
|
Application of the white crane rattan alkali in biological medicine
|
|
CN109503530A
|
|
A method of preparing Caesalmin F
|
|
CN109394769A
|
|
A kind of antithyroid cancer purposes of pyrimidine derivatives
|
|
CN109444292A
|
|
A kind of HPLC method separating (R)-methychlothiazide and (S)-methychlothiazide
|
|
CN109342612A
|
|
A kind of HPLC method separating (R)-bendroflumethiazide and (S)-bendroflumethiazide
|
|
CN109358138A
|
|
A kind of efficient liquid-phase chromatography method separating (R)-bendroflumethiazide and (S)-bendroflumethiazide
|
|
CN109358139A
|
|
A kind of efficient liquid-phase chromatography method separating (R)-methychlothiazide and (S)-methychlothiazide
|
